Published Year: 2020
Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030
The global femtech market was valued at $560.5 million in 2018 and is expected to be valued at...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Inclusions and Exclusions
1.1.1 Inclusions
1.1.2 Exclusions
2.1 Key Questions Answered in the Report
3.1 In-Vitro Fertilization: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
4.1 Market Definition
4.1.1 Steps Involved in IVF
4.1.2 Additional IVF Procedures
4.2 Market Size and Growth Potential, $Million, 2019-2030
4.3 Global IVF Market: Future Potential
4.4 Impact of COVID-19 on In-Vitro Fertilization Market
5.1 Policies and Regulatory Framework
5.1.1 Overview
5.1.2 International Federation of Gynecology and Obstetrics (FIGO)
5.1.3 Regulatory Framework in the U.S.
5.1.4 International Federation of Fertility Societies (IFFS)
5.1.5 Regulatory Framework in EU4 and U.K.
5.1.6 Regulatory Framework in Asia-Pacific
5.1.7 Asia-Pacific Initiative on Reproduction (ASPIRE)
5.2 Reimbursement Analysis
5.2.1 U.S.
5.2.2 EU4 and U.K.
5.2.3 Asia-Pacific
5.3 Patent Analysis
5.3.1 By Country
5.3.2 By Year
5.4 Cost and Pricing Trends
6.1 Overview
6.2 Market Drivers
6.2.1 Growth in Median Age of First-Time Motherhood and Declining Fertility Rates
6.2.2 High Success Rate of IVF Treatment
6.2.3 Increasing Demand for Infertility Treatment to Support Aging Population
6.2.4 Impact of Fertility Tourism
6.3 Market Challenges
6.3.1 Unaffordable Cost of Assisted Reproductive Techniques (ART) and Genetic Testing in Low- and Middle- Income Countries
6.3.2 Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in Some Under-Developed and Developing Nations
6.3.3 Ethical Issues and Social Justice
6.4 Market Opportunities
6.4.1 Technological Advancements of Time-Lapse Technology
6.4.2 Advances in Embryo Biopsy and Genetic Screening
7.1 Overview
7.2 Key Strategies and Development (Suppliers)
7.2.1 Synergistic Activities
7.2.2 Regulatory Accreditations, Recognitions, Investments, and Expansions
7.2.3 Product and Service Launches
7.2.4 Mergers and Acquisitions, Partnership, and Collaborations
7.2.5 Approvals
7.3 Market Share Analysis
7.4 Growth-Share Analysis
8.1 Overview
8.2 Systems
8.2.1 Gamete Collection and Sorting Systems
8.2.2 Sample Handling Systems
8.2.3 Storage and Maintenance Systems
8.2.4 Other IVF Systems
8.3 Media and Reagents
8.3.1 Embryo Culture Media and Reagents
8.3.2 Cryopreservation Media and Reagents
8.3.3 Gamete Processing Media and Reagents
8.3.4 Other Media and Reagents
8.3.5 Accessories and Consumables
9.1 Overview
9.2 Conventional IVF
9.3 IVF with Intracytoplasmic Sperm Injection (ICSI)
10.1 Overview
10.2 Fresh Donor
10.3 Fresh Non-donor
10.4 Frozen Donor
10.5 Frozen Non-donor
11.1 Overview
11.2 Commercial Labs
11.3 Fertility Clinics
11.4 Hospital Systems
11.5 Other End Users
12.1 Overview
12.1.1 Global In-Vitro Fertilization Market (by Region), 2019-2030
12.2 Growth Potential Analysis (by Country)
12.3 North America
12.3.1 Key Dynamics
12.3.2 U.S.
12.3.2.1 U.S. In-Vitro Fertilization Market
12.3.2.2 IVF Test Volume (Units), 2019-2030
12.3.2.3 Number of Operating IVF Labs
12.3.3 Canada
12.3.3.1 Canada In-Vitro Fertilization Market
12.3.3.2 IVF Test Volume (Units), 2019-2030
12.3.3.3 Number of Operating IVF Labs
12.3.4 North America In-Vitro Fertilization Market (by Procedure)
12.3.5 North America In-Vitro Fertilization Market (by End User)
12.4 Europe
12.4.1 Key Dynamics
12.4.2 Germany
12.4.2.1 IVF Test Volume (Units), 2019-2030
12.4.2.2 Number of Operating IVF Labs
12.4.3 France
12.4.3.1 IVF Test Volume (Units), 2019-2030
12.4.3.2 Number of Operating IVF Labs
12.4.4 U.K.
12.4.4.1 IVF Test Volume (Units), 2019-2030
12.4.4.2 Number of Operating IVF Labs
12.4.5 Italy
12.4.5.1 IVF Test Volume (Units), 2019-2030
12.4.5.2 Number of Operating IVF Labs
12.4.6 Spain
12.4.6.1 IVF Test Volume (Units), 2019-2030
12.4.6.2 Number of Operating IVF Labs
12.4.7 Netherlands
12.4.7.1 IVF Test Volume (Units), 2019-2030
12.4.7.2 Number of Operating IVF Labs (2019)
12.4.8 Russia
12.4.8.1 IVF Test Volume (Units), 2019-2030
12.4.8.2 Number of Operating IVF Labs
12.4.9 Rest-of-Europe
12.4.10 Europe In-Vitro Fertilization Market (by Procedure)
12.4.11 Europe In-Vitro Fertilization Market (by End User)
12.5 Asia-Pacific
12.5.1 Key Dynamics
12.5.2 Japan
12.5.2.1 IVF Test Volume (Units), 2019-2030
12.5.2.2 Number of Operating IVF Labs
12.5.3 China
12.5.3.1 IVF Test Volume (Units), 2019-2030
12.5.3.2 Number of Operating IVF Labs
12.5.4 Australia
12.5.4.1 IVF Test Volume (Units), 2019-2030
12.5.4.2 Number of Operating IVF Labs
12.5.5 India
12.5.5.1 IVF Test Volume (Units), 2019-2030
12.5.5.2 Number of Operating IVF Labs
12.5.6 South Korea
12.5.6.1 IVF Test Volume (Units), 2019-2030
12.5.6.2 Number of Operating IVF Labs
12.5.7 Singapore
12.5.7.1 IVF Test Volume (Units), 2019-2030
12.5.7.2 Number of Operating IVF Labs
12.5.8 Rest-of-APAC
12.5.8.1 IVF Test Volume (Units), 2019-2030
12.5.9 APAC In-Vitro Fertilization Market (by Procedure)
12.5.10 APAC In-Vitro Fertilization Market (by End User)
12.6 Latin America
12.6.1 Key Dynamics
12.6.2 Brazil
12.6.2.1 IVF Test Volume (Units), 2019-2030
12.6.2.2 Number of Operating IVF Labs
12.6.3 Mexico
12.6.3.1 IVF Test Volume (Units), 2019-2030
12.6.3.2 Number of Operating IVF Labs
12.6.4 Rest-of-Latin America
12.6.5 Latin America In-Vitro Fertilization Market (by Procedure)
12.6.6 Latin America In-Vitro Fertilization Market (by End User)
12.7 Rest-of-the-World
12.7.1 Rest-of-the-World In-Vitro Fertilization Market (by Procedure)
12.7.2 Rest-of-the-World In-Vitro Fertilization Market (by End User)
13.1 Overview
13.2 The Suppliers
13.3 The Cooper Companies Inc.
13.3.1 Company Overview
13.3.2 Role of the Cooper Companies Inc. in the Global IVF Market
13.3.3 Financials
13.3.3.1 Key Insights About Financial Health of the Company
13.3.4 SWOT Analysis
13.4 Vitrolife AB
13.4.1 Company Overview
13.4.2 Role of Vitrolife AB in the Global IVF market
13.4.3 Financials
13.4.3.1 Key Insights About Financial Health of the Company
13.4.4 SWOT Analysis
13.5 Illumina, Inc.
13.5.1 Company Overview
13.5.2 Role of Illumina, Inc. in the Global In-Vitro Fertilization Market
13.5.3 Financials
13.5.4 Key Insights About Financial Health of the Company
13.5.5 SWOT Analysis
13.6 Agilent Technologies, Inc.
13.6.1 Company Overview
13.6.2 Role of Agilent Technologies, Inc. in the Global In-Vitro Fertilization Market
13.6.3 Financials
13.6.4 Key Insights About Financial Health of the Company
13.6.5 SWOT Analysis
13.7 Cook Medical
13.7.1 Company Overview
13.7.2 Role of Cook Medical in the Global IVF market
13.7.3 SWOT Analysis
13.8 FUJIFILM Irvine Scientific
13.8.1 Company Overview
13.8.2 Role of FUJIFILM Irvine Scientific in the Global IVF market
13.8.3 SWOT Analysis
13.9 F. Hoffmann-La Roche Ltd
13.9.1 Company Overview
13.9.2 Role of F. Hoffmann-La Roche Ltd. in the Global In-Vitro Fertilization Market
13.9.3 Financials
13.9.4 Key Insights About Financial Health of the Company
13.9.5 SWOT Analysis
13.10 GE Healthcare
13.10.1 Company Overview
13.10.2 Role of GE Healthcare in the Global In-Vitro Fertilization Market
13.10.3 Financials
13.10.4 SWOT Analysis
13.11 Abbott Laboratories
13.11.1 Company Overview
13.11.2 Role of Abbott Laboratories plc in the Global In-Vitro Fertilization Market
13.11.3 Financials
13.11.4 Key Insights About Financial Health of the Company
13.11.5 SWOT Analysis
13.12 Thermo Fisher Scientific, Inc.
13.12.1 Company Overview
13.12.2 Role of Thermo Fisher Scientific, Inc. in the Global In-Vitro Fertilization Market
13.12.3 Financials
13.12.4 R&D Expenditure, 2018-2020
13.12.5 SWOT Analysis
13.13 Merck KGaA
13.13.1 Company Overview
13.13.2 Role of Merck KGaA in the Global In-Vitro Fertilization Market
13.13.3 Financials
13.13.4 SWOT Analysis
13.14 Esco Group of Companies
13.14.1 Company Overview
13.14.2 Role of Esco Group of Companies in the Global IVF Market
13.14.3 SWOT Analysis
13.15 IVFtech ApS
13.15.1 Company Overview
13.15.2 Role of IVFtech ApS in the Global IVF Market
13.15.3 SWOT Analysis
13.16 Kitazato Corporation
13.16.1 Company Overview
13.16.2 Role of Kitazato Corporation in the Global In-Vitro Fertilization Market
13.16.3 SWOT Analysis
13.17 Service Providers
13.18 Care Fertility
13.18.1 Company Overview
13.18.2 Role of Care Fertility in the Global In-Vitro Fertilization Market
13.18.3 SWOT Analysis
13.19 Laboratory Corporation of America Holdings (Labcorp)
13.19.1 Company Overview
13.19.2 Role of Labcorp in the Global In-Vitro Fertilization Market
13.19.3 Financials
13.19.4 SWOT Analysis
13.20 Genea Limited
13.20.1 Company Overview
13.20.2 Role of Genea Limited in the Global In-Vitro Fertilization Market
13.20.3 SWOT Analysis
13.21 Natera, Inc.
13.21.1 Company Overview
13.21.2 Role of Natera Inc. in the Global In-Vitro Fertilization Market
13.21.3 Financials
13.21.4 SWOT Analysis
13.22 Invitae Corporation
13.22.1 Company Overview
13.22.2 Role of Invitae Corporation in the Global In-Vitro Fertilization Market
13.22.3 Financials
13.22.4 SWOT Analysis
13.23 Progyny, Inc.
13.23.1 Company Overview
13.23.2 Role of Progyny, Inc. in the Global In-Vitro Fertilization Market
13.23.3 Financials
13.23.4 SWOT Analysis
13.24 Kaiser Permanente
13.24.1 Company Overview
13.24.2 Role of Kaiser Permanente in the Global In-Vitro Fertilization Market
13.24.3 SWOT Analysis
13.25 Boston IVF
13.25.1 Company Overview
13.25.2 Role of Boston IVF in the Global In-Vitro Fertilization Market
13.25.3 SWOT Analysis
13.26 Monash IVF Group
13.26.1 Company Overview
13.26.2 Role of Monash IVF in the Global In-Vitro Fertilization Market
13.26.3 Financials
13.26.4 SWOT Analysis
Table 5.1: Cost of Different Types of IVF Procedures
Table 5.2: Cost of Genetic Testing for IVF
Table 8.1: Examples of Systems Offered by Key Companies
Table 8.2: Examples of Ovum Aspiration Pump Products Developed by Key Companies
Table 8.3: Examples of Imaging System Products Developed by Key Companies
Table 8.4: Examples of Micromanipulator Products Developed by Key Companies
Table 8.5: Examples of Laser System Products Developed by Key Companies
Table 8.6: Examples of Workstation and Cabinet Products Developed by Key Companies
Table 8.7: Examples of Incubator Products Developed by Key Companies
Table 8.8: Examples of Cryosystem Products Developed by Key Companies
Table 8.9: Examples of Analyzer and Regulator Products Developed by Key Companies
Table 8.10: Examples of Table Products Developed by Key Companies
Table 8.11: Examples of Witness System Products Developed by Key Companies
Table 8.12: Examples of Devices (under Others Category) Developed by Key Companies
Table 8.13: Examples of Reagent Types Offered by Key Companies
Table 8.14: Examples of Embryo Culture Media and Reagents Products Developed by Key Companies
Table 8.15: Examples of Cryopreservation Media and Reagents Developed by Key Companies
Table 8.16: Examples of Gamete Processing Media and Reagents Developed by Key Companies
Table 8.17: Examples of Media and Reagents (Others) Developed by Key Companies
Table 8.18: Examples of Accessories and Consumables Developed by Key Companies
Figure 1: Global In-Vitro Fertilization Market, $Million, 2020-2030
Figure 2: Global In-Vitro Fertilization: Impact Analysis
Figure 3: Global In-Vitro Fertilization Market (by Component), $Million, 2019, 2025, and 2030
Figure 4: Global In-Vitro Fertilization Market (by Product Type), $Million, 2019, 2025, and 2030
Figure 5: Global In-Vitro Fertilization Market (by Procedure), $Million, 2020 and 2030
Figure 6: Global IVF Market Share (by End User Type), 2020 and 2030
Figure 7: Global IVF Market (by Region), 2020 and 2030
Figure 2.1: Global In-Vitro Fertilization Market (by Segment)
Figure 3.1: Global In-Vitro Fertilization Market Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Process of IVF
Figure 4.2: Global In-Vitro Fertilization (IVF) Market, 2019-2030
Figure 4.3: Impact of COVID-19 on the Global In-Vitro Fertilization Market
Figure 5.1: Patent Analysis, by Country (2018-2021)
Figure 5.2: Patent Analysis, by Year (2018-2021)
Figure 7.1: Synergistic Activities (by Suppliers), July 2016-December 2020
Figure 7.2: Company Share (by Synergistic Activity), January 2016-December 2020
Figure 7.3: Regulatory Accreditations, Recognitions, Investments, and Expansions Share (by Company), January 2016-December 2020
Figure 7.4: Product and Service Launch Share by Company, January 2016-January 2020
Figure 7.5: M&A, Partnerships and Collaborations Share, January 2016-December 2020
Figure 7.6: Approvals (by Company), January 2016-January 2020
Figure 7.7: Market Share Analysis (by Suppliers), 2019
Figure 7.8: Growth-Share Matrix for Global In-Vitro Fertilization Market (by Company), 2019
Figure 7.9: Growth-Share Matrix for Global In-Vitro Fertilization Market (by Procedure), 2019
Figure 7.10: Growth Share Matrix for Global In-Vitro Fertilization Market (by Region), 2019
Figure 8.1: Global IVF Market (by Product), 2020 and 2030
Figure 8.2: Global IVF Systems Market, 2020-2030
Figure 8.3: Global IVF Devices Market (by Systems), 2020 and 2030
Figure 8.4: Global Gamete Collection and Sorting Systems Market, 2019-2030
Figure 8.5: Global IVF Sample Handling Systems Market, 2019-2030
Figure 8.6: Global IVF Storage and Maintenance Systems Market, 2019-2030
Figure 8.7: Global Other IVF Systems Market, 2019-2030
Figure 8.8: Global IVF Media and Reagents Market, 2019-2030
Figure 8.9: Global IVF Market (by Media and Reagents), 2020 and 2030
Figure 8.10: Global IVF Embryo Culture Media and Reagents Market, 2019-2030
Figure 8.11: Global IVF Cryopreservation Media and Reagents Market, 2019-2030
Figure 8.12: Global IVF Gamete Processing Media and Reagents Market, 2019-2030
Figure 8.13: Global IVF Other Media and Reagents Market, 2019-2030
Figure 8.14: Global IVF Accessories and Consumables Market, 2019-2030
Figure 9.1: Global IVF Market (by Type), 2020 and 2030
Figure 9.2: Global Conventional IVF Market, 2019-2030
Figure 9.3: Global IVF with ICSI Market, 2019-2030
Figure 10.1: Global IVF Market (by Procedure), 2020 and 2030
Figure 10.2: Global IVF Fresh Donor Market, 2019-2030
Figure 10.3: Global IVF Fresh Non-donor Market, 2019-2030
Figure 10.4: Global IVF Frozen Donor Market, 2019-2030
Figure 10.5: Global IVF Frozen Non-donor Market, 2019-2030
Figure 11.1: Global IVF Market (by End Users), 2020 and 2030
Figure 11.2: Global IVF Commercial Labs Market, 2019-2030
Figure 11.3: Global IVF Fertility Clinics Market, 2019-2030
Figure 11.4: Global IVF Hospital Systems Market, 2019-2030
Figure 11.5: Global IVF Other End Users Market, 2019-2030
Figure 12.1: Global In-Vitro Fertilization Market (by Region)
Figure 12.2: Global In-Vitro Fertilization Market (by Region), $Million, 2020 and 2030
Figure 12.3: Global In-Vitro Fertilization Market (by Region), $Million, 2019-2030
Figure 12.4: North America In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.5: North America: Market Dynamics
Figure 12.6: Revenue Contributions of Various Countries in North America, 2019 and 2030
Figure 12.7: U.S. In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.8: Canada In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.9: North America In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
Figure 12.10: North America In-Vitro Fertilization Market (by End User), 2019-2030
Figure 12.11: Europe In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.12: Europe: Market Dynamics
Figure 12.13: Revenue Contributions of Various Countries in Europe, $Million, 2019 and 2030
Figure 12.14: Germany In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.15: France In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.16: U.K. In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.17: Italy In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.18: Spain In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.19: Netherlands In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.20: Russia In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.21: Rest-of-Europe In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.22: Europe In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
Figure 12.23: Europe In-Vitro Fertilization Market (by End User), $Million, 2019-2030
Figure 12.25: Asia-Pacific: Market Dynamics
Figure 12.26: Revenue Contributions of Various Countries in Asia-Pacific, $Million, 2019 and 2030
Figure 12.27: Japan In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.28: China In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.29: Australia In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.30: India In-Vitro fertilization Market, $Million, 2019-2030
Figure 12.31: South Korea In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.32: Singapore In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.33: Rest-of-APAC In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.34: APAC In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
Figure 12.35: APAC In-Vitro Fertilization Market (by End User), $Million, 2019-2030
Figure 12.36: Latin America In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.37: Latin America: Market Dynamics
Figure 12.38: Revenue Contributions of Various Countries in Latin America, $Million, 2019 and 2030
Figure 12.39: Brazil In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.40: Mexico In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.41: RoLA In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.42: Latin America In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
Figure 12.43: Latin America In-Vitro Fertilization Market (by End User), $Million, 2019-2030
Figure 12.44: Rest-of-the-World In-Vitro Fertilization Market, $Million, 2019-2030
Figure 12.45: Rest-of-the-World In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
Figure 12.46: Rest-of-the-World In-Vitro Fertilization Market (by End User), $Million, 2019-2030
Figure 13.1: Total Number of Companies Profiled
Figure 13.2: Total Number of Companies Profiled: Ratio of Suppliers to Service Providers
Figure 13.3: The Cooper Companies Inc.: Product Portfolio for Global IVF market
Figure 13.4: The Cooper Companies Inc.: Overall Financials, 2018-2020
Figure 13.5: The Cooper Companies Inc.: Revenue (by Segment), 2018-2020
Figure 13.6: The Cooper Companies Inc.: Revenue (by CooperSurgical Category), 2018-2020
Figure 13.7: The Cooper Companies Inc.: Revenue (by Region), 2018-2020
Figure 13.8: The Cooper Companies Inc.: R&D Expenditure (2018-2020)
Figure 13.9: The Cooper Companies Inc.: SWOT Analysis
Figure 13.10: Vitrolife AB: Product Portfolio for Global IVF market
Figure 13.11: Vitrolife AB: Overall Financials, 2018-2020
Figure 13.12: Vitrolife AB: Revenue (by Segment), 2018-2020
Figure 13.13: Vitrolife AB: Revenue (by Region), 2018-2020
Figure 13.14: Vitrolife AB: R&D Expenditure (2018-2020)
Figure 13.15: Vitrolife AB: SWOT Analysis
Figure 13.16: Illumina, Inc.: Overall Product Portfolio
Figure 13.17: Illumina, Inc.: Overall Financials, 2018-2020
Figure 13.18: Illumina, Inc.: Revenue (by Segment), 2018-2020
Figure 13.19: Illumina, Inc.: Revenue (by Region), 2018-2020
Figure 13.20: Illumina, Inc.: R&D Expenditure, 2018-2020
Figure 13.21: Illumina, Inc.: SWOT Analysis
Figure 13.22: Agilent Technologies, Inc.: Overall Product Portfolio
Figure 13.23: Agilent Technologies, Inc.: Overall Financials, 2018-2020
Figure 13.24: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
Figure 13.25: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 13.26: Agilent Technologies, Inc. R&D Expenditure, 2018-2020
Figure 13.27: Agilent Technologies, Inc.: SWOT Analysis
Figure 13.28: Cook Medical: Product Portfolio for Global IVF Market
Figure 13.29: Cook Medical: SWOT Analysis
Figure 13.30: FUJIFILM Irvine Scientific: Product Portfolio for Global IVF market
Figure 13.31: FUJIFILM Irvine Scientific: SWOT Analysis
Figure 13.32: F. Hoffmann-La Roche Ltd.: Overall Product Portfolio
Figure 13.33: F. Hoffmann-La Roche Ltd.: Overall Financials, 2018-2020
Figure 13.34: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), 2018-2020
Figure 13.35: F. Hoffmann-La Roche Ltd.: Revenue (by Region), 2018-2020
Figure 13.36: F. Hoffmann-La Roche Ltd.: R&D Expenditure, 2018-2020
Figure 13.37: F. Hoffmann-La Roche Ltd.: SWOT Analysis
Figure 13.38: GE Healthcare: Product Portfolio
Figure 13.39: GE Healthcare: Overall Financials, 2018-2020
Figure 13.40: GE Healthcare Net Revenue (by Segment), 2018-2020
Figure 13.41: GE Healthcare (by Region), 2018-2020
Figure 13.42: GE Healthcare R&D Expense, 2018-2020
Figure 13.43: GE Healthcare SWOT Analysis
Figure 13.44: Abbott Laboratories: Overall Product Portfolio
Figure 13.45: Abbott Laboratories: Overall Financials, 2018-2020
Figure 13.46: Abbott Laboratories: Revenue (by Segment), 2018-2020
Figure 13.47: Abbott Laboratories: Revenue (by Region), 2018-2020
Figure 13.48: Abbott Laboratories: R&D Expenditure, 2018-2020
Figure 13.49: Abbott Laboratories: SWOT Analysis
Figure 13.50: Thermo Fisher Scientific, Inc.: Overall Product Portfolio
Figure 13.51: Thermo Fisher Scientific, Inc.: In-Vitro Fertilization Product Portfolio Category
Figure 13.52: Thermo Fisher Scientific, Inc.: Overall Financials, 2018-2020
Figure 13.53: Thermo Fisher Scientific, Inc. Net Revenue (by Business Segment), 2018-2020
Figure 13.54: Thermo Fisher Scientific, Inc. Net Revenue (by Region), 2018-2020
Figure 13.55: Thermo Fisher Scientific, Inc.: R&D Expense, 2018-2020
Figure 13.56: Thermo Fisher Scientific, Inc.: SWOT Analysis
Figure 13.57: Merck KGaA: Overall Product Portfolio
Figure 13.58: Merck KGaA: Overall Financials, 2018-2020
Figure 13.59: Merck KGaA Net Revenue (by Business Segment), 2018-2020
Figure 13.60: Merck KGaA Net Revenue (by Region), 2018-2020
Figure 13.61: Merck KGaA: R&D Expense, 2018-2020
Figure 13.62: Merck KGaA: SWOT Analysis
Figure 13.63: Esco Group of Companies: Product Portfolio for Global IVF market
Figure 13.64: Esco Group of Companies: SWOT Analysis
Figure 13.65: IVFtech ApS: Product Portfolio for Global IVF market
Figure 13.66: IVFtech ApS: SWOT Analysis
Figure 13.67: Kitazato Corporation: Overall Product Portfolio
Figure 13.68: Kitazato Corporation: SWOT Analysis
Figure 13.69: Care Fertility: Overall Product Portfolio
Figure 13.70: Care Fertility: SWOT Analysis
Figure 13.71: Labcorp: Overall Service Portfolio
Figure 13.72: Labcorp: Overall Financials, 2018-2020
Figure 13.73: Labcorp Net Revenue (by Business Segment), 2018-2020
Figure 13.74: Labcorp Net Revenue (by Region), 2018-2020
Figure 13.75: Labcorp: SWOT Analysis
Figure 13.76: Genea Limited: Overall Product Portfolio
Figure 13.77: Genea Limited: SWOT Analysis
Figure 13.78: Natera Inc.: Overall Product Portfolio
Figure 13.79: Natera, Inc.: Overall Financials, 2016-2018
Figure 13.80: Natera, Inc Net Revenue (by Business Segment), 2016-2018
Figure 13.81: Natera, Inc. Net Revenue (by Region), 2016-2018
Figure 13.82: Natera, Inc Research and Development Revenue, 2016-2018
Figure 13.83: Natera Inc.: SWOT Analysis
Figure 13.84: Invitae Corporation: Overall Product Portfolio
Figure 13.85: Invitae Corporation: Overall Financials, 2018-2020
Figure 13.86: Invitae Corporation Net Revenue (by Region), 2018-2020
Figure 13.87: Invitae Corporation Research and Development Revenue, 2018-2020
Figure 13.88: Invitae Corporation: SWOT Analysis
Figure 13.89: Progyny, Inc.: Overall Product Portfolio
Figure 13.90: Progyny Inc.: Overall Financials, 2018-2020
Figure 13.91: Progyny, Inc.: SWOT Analysis
Figure 13.92: Kaiser Permanente: Overall Product Portfolio
Figure 13.93: Kaiser Permanente: SWOT Analysis
Figure 13.94: Boston IVF: Overall Product Portfolio
Figure 13.95: Boston IVF: SWOT Analysis
Figure 13.96: Monash IVF: Overall Product Portfolio
Figure 13.97: Monash IVF: Overall Financials, 2018-2020
Figure 13.98: Monash IVF: SWOT Analysis
Report Description
|
Market Report Coverage - In-Vitro Fertilization |
|||
|
Base Year |
2019 |
Market Size in 2019 |
$19,375.0 Million |
|
Forecast Period |
2020-2030 |
Value Projection and Estimation by 2030 |
$51,505.1 Million |
|
CAGR During Forecast Period |
9.37% |
Number of Tables |
20 |
|
Number of Pages |
301 |
Number of Figures |
197 |
|
Research Hours |
600 |
|
|
|
Market Segmentation |
• Component – Product, Services • Product – Systems, Media and Reagents, Accessories and Consumables • Services – Types, Procedures, End Users |
||
|
Regional Segmentation |
• North America – U.S., Canada • Europe – Germany, France, Italy, U.K., Spain, Russia, Netherlands • Asia-Pacific – Japan, China, India, South Korea, Australia, Singapore • Latin America – Brazil, Mexico • Rest-of-the-World – the Middle East and Africa |
||
|
Growth Drivers |
• Growth in Median Age of First-Time Motherhood and Declining Fertility Rates • High Success Rate of IVF Treatment • Increasing Demand for Infertility Treatment to Support Aging Population • Impact of Fertility Tourism |
||
|
Market Challenges |
• Unaffordable Cost of Assisted Reproductive Techniques (ART) and Genetic Testing in Low- and Middle- Income Countries • Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in Some Under-Developed and Developing Nations • Ethical Issues and Social Justice |
||
|
Market Opportunities |
• Technological Advancements of Time-Lapse Technology • Advances in Embryo Biopsy and Genetic Screening |
||
|
Key In-Vitro Fertilization Companies Profiled |
Suppliers - CooperSurgical, Inc., Vitrolife AB, Illumina, Inc., Agilent Technologies, Inc., Cook Medical Inc., Fujifilm Irvine Scientific Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Abbott Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Esco Micro Pte. Ltd., IVFtech APS, and Kitazato Corporation. Service Providers - CARE Fertility, Laboratory Corporation of America Holdings, Genea Limited, Natera, Inc., Invitae Corporation, Kaiser Permanente, Progyny, Inc., Boston IVF, and Monash IVF Group |
||
Key Questions Answered in this Report:
• What is in-vitro fertilization?
• What are different types of systems, media, and reagents available in the market, and what are they used for? What are the key companies offering these devices and reagents? What would be the global market value for each of these systems, media, and reagents for the time between 2020 and 2030?
• Based on systems, which IVF system type is anticipated to witness a massive rise in the demand in the forecast period? Based on reagents, which reagent type is anticipated to witness a massive rise in the demand in the forecast period?
• What are the different testing services involved in IVF procedures, and what are the key companies offering them? What would be the global market value for services for the period 2019-2030?
• What are the major drivers, challenges, and opportunities of the global IVF market?
• What are the key developmental strategies implemented by the key players to stand out in this market?
• What are the leading companies dominating the global IVF market? What is the share of these companies in the global IVF market?
• What are the regulations pertaining to the global IVF market? What initiatives are implemented by different government bodies regulating the development and commercialization of IVF devices?
• By end-user type, what would the market value of the leading segments of the global IVF market be? By procedure type, what would the market value of the leading segments of the global IVF market be?
• How will each segment of the global IVF market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2030?
• How will the industry evolve during the forecast period 2020-2030?
• What is the market scenario for the IVF services market in different regions?
• What are the key trends of different regions in the IVF market? Which country would contribute to the highest sales of the IVF market during the forecast period 2020-2030?
Market Overview
Infertility is a serious health issue worldwide, affecting approximately 8%–10% of couples worldwide. According to CDC, 2013 and Office on Women’s Health, 2019 reports, about 9% of men and 10% of women aged 15 to 44 reported infertility problems in the U.S., and according to the Reproductive Biological Endocrinology, 2015 report, around 48.5 million couples experience infertility, globally. In response to these issues, countries across the globe are striving hard to increase their fertility rates, thereby promoting high adoption of assisted reproductive technologies (ART). ART are cutting-edge technologies that help to treat infertility by manipulating sperm and/or eggs outside the human body.
The global in-vitro fertilization market consists of systems, media, and reagents, and pharmaceuticals used to carry out the entire procedure, from monitoring and stimulating a woman's ovulatory process to the final implantation of the embryo into the concerned woman’s fallopian tube to bringing out a successful pregnancy. The increasing incidence of infertility owing to lifestyle changes, such as an increase in the median age of first-time motherhood, is a major factor contributing to the growth of the global in-vitro fertilization market.
Our healthcare experts have found in-vitro fertilization to be one of the most rapidly evolving techniques, and the global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030. An increase in the trend of delayed pregnancies, changing lifestyles in urban areas, and increased age of parenthood bolster the growth of the global IVF market. The following report presents the reader with an opportunity to unlock comprehensive insights with respect to the global IVF market and helps in forming well-informed strategic decisions. The market research study also offers a wide perspective of the different types of products and services available in the market and their impact on the healthcare sector by providing critical insights into the direction of its future expansion.
The global IVF market is largely dominated by companies such as The Cooper Companies Inc., Vitrolife AB, Cook Medical, Merck KGaA, Fujifilm Holdings Corporation, and other enterprises. Declining fertility rates, changing lifestyles in urban areas, and increased age of parenthood are expected to be the primary factors driving the growth of the global IVF market. Government funding encouraging infertility treatments in addition to the industrial revolutions and technological advancements in the ART field is further expected to accelerate the growth of the market during the forecast period 2020-2030.
Based on region, Europe is the dominating region for the global in-vitro fertilization market in the year 2019. Low fertility rates and flexible government regulations are the two most prominent factors contributing to the growth of the IVF market in Europe. In the Asia-Pacific region, China, Japan, India, Australia, and New Zealand are among the top five countries generating the highest revenues compared to other countries of the region.
Within the research report, the market is segmented based on product, services, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The global IVF market is distributed among suppliers and service providers. Cooper Surgical, Vitrolife AB, Merck KGaA, and Cook Medical are some of the key suppliers to this market. Among the service providers, companies like Progyny, Natera, and Invitae Corp. are the major service providers offering IVF diagnostic and testing services.
The global in-vitro fertilization market is currently dominated by Cooper Companies, Inc., followed by Vitrolife AB. The market dominance of Cooper Companies, Inc. can be attributed to a large product offering in media, reagents, and consumables segments. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, kits, and accessories) and systems.
Global In-Vitro Fertilization Market
Focus on Products, Types, Procedures, and End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030
Some Faq's
Frequently Asked Questions
The in-vitro fertilization market in the coming years is expected to grow at a CAGR of 9.37% during the forecast period from 2020-2030.
Opportunities that can boost the growth of the market include technological advancements of time-lapse technology and advances in embryo biopsy and genetic screening.
Factors driving the growth of the market include growth in median age of first-time motherhood and declining fertility rates and high success rate of ivf treatment, among others.
Challenges that can restrict the growth of the market include unaffordable cost of assisted reproductive techniques (art) and genetic testing in low- and middle- income countries and ethical issues and social justice, among others.
Key players operating in the market include CARE Fertility, Laboratory Corporation of America Holdings, Genea Limited, Natera, Inc., Invitae Corporation, Kaiser Permanente, Progyny, Inc., Boston IVF, and Monash IVF Group.
Similar Product
You may also like
Published Year: 2019
Asia-Pacific In-Vitro Fertilization Market – Analysis and Forecast, 2019-2029: Focus on Device Typ
The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a...